Metabolic effects of free fatty acids during endotoxaemia in a porcine model free fatty acid inhibition of growth hormone secretion as a potential catabolic feedback mechanism

Hormone and Metabolic Research

Volumn 42, Issue 5, 2010, Pages 348-352

  Buhl, M ^a   Gjedsted, J ^a   Granfeldt, A ^a   Larsen, P O ^a   Schmitz, O ^a,b   Tonnesen E ^a   Moller N ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Hyperinsulinaemic euglycaemic clamp; Inflammation; Insulin sensitivity; Intralipid ; Pig model

Indexed keywords

ADRENALIN; ENDOTOXIN; FATTY ACID; GLUCAGON; GLUCOSE; GROWTH HORMONE; HEPARIN; HYDROCORTISONE; INSULIN; INTRALIPID; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; ENDOTOXEMIA; EXPERIMENTAL MODEL; FEEDBACK SYSTEM; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HYDROCORTISONE BLOOD LEVEL; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN DEPLETION; SWINE;

ANIMALS; ENDOTOXEMIA; ENDOTOXINS; EPINEPHRINE; FATTY ACIDS, NONESTERIFIED; FEEDBACK, PHYSIOLOGICAL; FEMALE; GLUCAGON; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIPOPOLYSACCHARIDES; NOREPINEPHRINE; SWINE;

SUIDAE; SUS;

EID: 77951994667     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1248297     Document Type: Article

References (46)

1. Lind L, Lithell H. Impaired glucose and lipid metabolism seen in intensive care patients is related to severity of illness and survival. Clin Intensive Care 1994 5 100-105 (Pubitemid 24284948)
2. Nogueira AC, Kawabata V, Biselli P, Lins MH, Valeri C, Seckler M, Hoshino W, Junior LG, Bernik MM, de Andrade Machado JB, Martinez MB, Lotufo PA, Caldini EG, Martins E, Curi R, Soriano FG. Changes in plasma free fatty acid levels in septic patients are associated with cardiac damage and reduction in heart rate variability. Shock 2007 29 342-348 (Pubitemid 351271705)
3. Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den BG. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 2004 89 219-226 (Pubitemid 38183885)
4. Streat SJ, Beddoe AH, Hill GL. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma 1987 27 262-266
5. Van den Berghe G, de ZF, Bouillon R. Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998 83 1827-1834 (Pubitemid 28496301)
6. Chambrier C, Laville M, Rhzioual BK, Odeon M, Bouletreau P, Beylot M. Insulin sensitivity of glucose and fat metabolism in severe sepsis. Clin Sci (Lond) 2000 99 321-328
7. Shangraw RE, Jahoor F, Miyoshi H, Neff WA, Stuart CA, Herndon DN, Wolfe RR. Differentiation between septic and postburn insulin resistance. Metabolism 1989 38 983-989 (Pubitemid 19254998)
8. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001 345 1359-1367
9. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van WE, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006 354 449-461 (Pubitemid 43200296)
10. Moller N, Nair KS. Diabetes and protein metabolism. Diabetes 2008 57 3-4
11. Moller N, Otto Lunde JJ. Effects of Growth Hormone on Glucose, Lipid and Protein Metabolism in Human Subjects. Endocr Rev 2009 152-177
12. Bentham J, Rodriguez-Arnao J, Ross RJ. Acquired growth hormone resistance in patients with hypercatabolism. Horm Res 1993 40 87-91 (Pubitemid 23349948)
13. Ross R, Miell J, Freeman E, Jones J, Matthews D, Preece M, Buchanan C. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I. Clin Endocrinol (Oxf) 1991 35 47-54
14. Norrelund H, Nair KS, Jorgensen JO, Christiansen JS, Moller N. The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown. Diabetes 2001 50 96-104 (Pubitemid 32047987)
15. Norrelund H, Nair KS, Nielsen S, Frystyk J, Ivarsen P, Jorgensen JO, Christiansen JS, Moller N. The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone. J Clin Endocrinol Metab 2003 88 4371-4378 (Pubitemid 37153745)
16. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999 341 785-792 (Pubitemid 29420473)
17. Gallin JI, Kaye D, OLeary WM. Serum lipids in infection. N Engl J Med 1969 281 1081-1086
18. Nishishita S. Studies on the fluctuation of the lipoid content of the blood in the fever period. Jpn J Exper Med 1941 97-107
19. Samra JS, Summers LKM, Frayn KN. Sepsis and fat metabolism. Brit J Surg 1996 83 1186-1196
20. Wymann MP, Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol 2008 9 162-176 (Pubitemid 351158917)
21. Pilz S, Scharnagl H, Tiran B, Seelhorst U, Wellnitz B, Boehm BO, Schaefer JR, Marz W. Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J Clin Endocrinol Metab 2006 91 2542-2547 (Pubitemid 44024615)
22. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994 343 155-158 (Pubitemid 24028646)
23. Schroder NW, Heine H, Alexander C, Manukyan M, Eckert J, Hamann L, Gobel UB, Schumann RR. Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J Immunol 2004 173 2683-2691 (Pubitemid 39063129)
24. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006 116 3015-3025 (Pubitemid 44684486)
25. Song MJ, Kim KH, Yoon JM, Kim JB. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 2006 346 739-745 (Pubitemid 43913680)
26. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996 97 2859-2865 (Pubitemid 26197099)
27. Widmaier EP. Metabolic feedback in mammalian endocrine systems. Horm Metab Res 1992 24 147-153
28. Quabbe HJ, Bratzke HJ, Siegers U, Elban K. Studies on the relationship between plasma free fatty acids and growth hormone secretion in man. J Clin Invest 1972 51 2388-2398
29. Casanueva FF, Villanueva L, Dieguez C, Diaz Y, Cabranes JA, Szoke B, Scanlon MF, Schally AV, Fernandez-Cruz A. Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. J Clin Endocrinol Metab 1987 65 634-642 (Pubitemid 17160242)
30. Buhl M, Gjedsted J, Granfeldt A, Larsen PO, Chew M, Moller N, Tonnesen E. Circulating free fatty acids do not contribute to the acute systemic inflammatory response. An experimental study in porcine endotoxaemia. Basic Clin Pharmacol Toxicol 2009 104 1-8
31. Harano Y, Ohtsuki M, Ida M, Kojima H, Harada M, Okanishi T, Kashiwagi A, Ochi Y, Uno S, Shigeta Y. Direct automated assay method for serum or urine levels of ketone bodies. Clin Chim Acta 1985 151 177-183 (Pubitemid 15248325)
32. Orskov H, Thomsen HG, Yde H. Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature 1968 219 193-195
33. Carstensen E, Yudkin JS. Platelet catecholamine concentrations after short-term stress in normal subjects. Clin Sci (Lond) 1994 86 35-41 (Pubitemid 24034705)
34. Moller N, Schmitz O, Porksen N, Moller J, Jorgensen JO. Dose-response studies on the metabolic effects of a growth hormone pulse in humans. Metabolism 1992 41 172-175
35. Van den Berghe G. Novel insights into the neuroendocrinology of critical illness. Eur J Endocrinol 2000 143 1-13 (Pubitemid 30482194)
36. Briard N, Rico-Gomez M, Guillaume V, Sauze N, Vuaroqueaux V, Dadoun F, Le BY, Oliver C, Dutour A. Hypothalamic mediated action of free fatty acid on growth hormone secretion in sheep. Endocrinology 1998 139 4811-4819 (Pubitemid 28533426)
37. McCann SM, Kimura M, Karanth S, Yu WH, Mastronardi CA, Rettori V. The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection. Ann N Y Acad Sci 2000 917 4-18
38. Beishuizen A, Thijs LG. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J Endotoxin Res 2003 9 3-24 (Pubitemid 36322480)
39. Migrenne S, Magnan C, Cruciani-Guglielmacci C. Fatty acid sensing and nervous control of energy homeostasis. Diabetes Metab 2007 33 177-182 (Pubitemid 46856252)
40. van der Poll T, Romijn JA, Endert E, Borm JJ, Buller HR, Sauerwein HP. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 1991 261 457-465
41. Moller N, Beckwith R, Butler PC, Christensen NJ, Orskov H, Alberti KG. Metabolic and hormonal responses to exogenous hyperthermia in man. Clin Endocrinol (Oxf) 1989 30 651-660 (Pubitemid 19152822)
42. Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL. Insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab 2000 85 3770-3778
43. Vary TC, Drnevich D, Jurasinski C, Brennan WA Jr. Mechanisms regulating skeletal muscle glucose metabolism in sepsis. Shock 1995 3 403-410
44. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963 1 785-789
45. Levraut J, Ciebiera JP, Chave S, Rabary O, Jambou P, Carles M, Grimaud D. Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med 1998 157 1021-1026 (Pubitemid 28225163)
46. Vary TC, Siegel JH. Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver. Am J Physiol 1989 256 445